These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2033578)

  • 1. Benzyloxazolidine-2,4-diones as potent hypoglycemic agents.
    Dow RL; Bechle BM; Chou TT; Clark DA; Hulin B; Stevenson RW
    J Med Chem; 1991 May; 34(5):1538-44. PubMed ID: 2033578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antihyperglycemic activity of new 1,2,4-oxadiazolidine-3,5-diones.
    Malamas MS; Sredy J; McCaleb M; Gunawan I; Mihan B; Sullivan D
    Eur J Med Chem; 2001 Jan; 36(1):31-42. PubMed ID: 11231047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel thiazolidine-2,4-diones as potent euglycemic agents.
    Hulin B; Clark DA; Goldstein SW; McDermott RE; Dambek PJ; Kappeler WH; Lamphere CH; Lewis DM; Rizzi JP
    J Med Chem; 1992 May; 35(10):1853-64. PubMed ID: 1588563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substituted dihydrobenzopyran and dihydrobenzofuran thiazolidine-2,4-diones as hypoglycemic agents.
    Clark DA; Goldstein SW; Volkmann RA; Eggler JF; Holland GF; Hulin B; Stevenson RW; Kreutter DK; Gibbs EM; Krupp MN
    J Med Chem; 1991 Jan; 34(1):319-25. PubMed ID: 1992133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quaternary oxazolylpyridinium salts. Oral hypoglycemic agents.
    Wiegand GE; Bauer VJ; Safir SR; Blickens DA; Riggi SJ
    J Med Chem; 1969 Sep; 12(5):943-4. PubMed ID: 5812229
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies on antidiabetic agents. VII. Synthesis and hypoglycemic activity of 4-oxazoleacetic acid derivatives.
    Meguro K; Tawada H; Sugiyama Y; Fujita T; Kawamatsu Y
    Chem Pharm Bull (Tokyo); 1986 Jul; 34(7):2840-51. PubMed ID: 3769086
    [No Abstract]   [Full Text] [Related]  

  • 7. Substituted tetrahydropyrrolo[2,1-b]oxazol-5(6H)-ones and tetrahydropyrrolo[2,1-b]thiazol-5(6H)-ones as hypoglycemic agents.
    Aicher TD; Balkan B; Bell PA; Brand LJ; Cheon SH; Deems RO; Fell JB; Fillers WS; Fraser JD; Gao J; Knorr DC; Kahle GG; Leone CL; Nadelson J; Simpson R; Smith HC
    J Med Chem; 1998 Nov; 41(23):4556-66. PubMed ID: 9804695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel 5-(3-aryl-2-propynyl)-5-(arylsulfonyl)thiazolidine-2,4-diones as antihyperglycemic agents.
    Wrobel J; Li Z; Dietrich A; McCaleb M; Mihan B; Sredy J; Sullivan D
    J Med Chem; 1998 Mar; 41(7):1084-91. PubMed ID: 9544208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New azolidinediones as inhibitors of protein tyrosine phosphatase 1B with antihyperglycemic properties.
    Malamas MS; Sredy J; Gunawan I; Mihan B; Sawicki DR; Seestaller L; Sullivan D; Flam BR
    J Med Chem; 2000 Mar; 43(5):995-1010. PubMed ID: 10715163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydroxyurea derivatives as hypoglycemic agents.
    Goldstein SW; McDermott RE; Gibbs EM; Stevenson RW
    J Med Chem; 1993 Jul; 36(15):2238-40. PubMed ID: 8340926
    [No Abstract]   [Full Text] [Related]  

  • 11. Hypoglycemic activity of a series of alpha-alkylthio and alpha-alkoxy carboxylic acids related to ciglitazone.
    Hulin B; Newton LS; Lewis DM; Genereux PE; Gibbs EM; Clark DA
    J Med Chem; 1996 Sep; 39(20):3897-907. PubMed ID: 8831756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel spirosuccinimides with incorporated isoindolone and benzisothiazole 1,1-dioxide moieties as aldose reductase inhibitors and antihyperglycemic agents.
    Wrobel J; Dietrich A; Woolson SA; Millen J; McCaleb M; Harrison MC; Hohman TC; Sredy J; Sullivan D
    J Med Chem; 1992 Nov; 35(24):4613-27. PubMed ID: 1469692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perfluorocarbon-based antidiabetic agents.
    Kees KL; Smith TM; McCaleb ML; Prozialeck DH; Cheeseman RS; Christos TE; Patt WC; Steiner KE
    J Med Chem; 1992 Mar; 35(5):944-53. PubMed ID: 1548684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-(2-Benzoylphenyl)-L-tyrosine PPARgamma agonists. 1. Discovery of a novel series of potent antihyperglycemic and antihyperlipidemic agents.
    Henke BR; Blanchard SG; Brackeen MF; Brown KK; Cobb JE; Collins JL; Harrington WW; Hashim MA; Hull-Ryde EA; Kaldor I; Kliewer SA; Lake DH; Leesnitzer LM; Lehmann JM; Lenhard JM; Orband-Miller LA; Miller JF; Mook RA; Noble SA; Oliver W; Parks DJ; Plunket KD; Szewczyk JR; Willson TM
    J Med Chem; 1998 Dec; 41(25):5020-36. PubMed ID: 9836620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and antifungal activity of benzo[d]oxazole-4,7-diones.
    Ryu CK; Lee RY; Kim NY; Kim YH; Song AL
    Bioorg Med Chem Lett; 2009 Oct; 19(20):5924-6. PubMed ID: 19733068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Euglycaemic and biological activities of novel thiazolidine-2,4-dione derivatives.
    de Nanteuil G; Herve Y; Duhault J; Espinal J; Boulanger M; Ravel D
    Arzneimittelforschung; 1995 Nov; 45(11):1176-81. PubMed ID: 8929235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antihyperglycemic activity of novel naphthalenyl 3H-1,2,3,5-oxathiadiazole 2-oxides.
    Ellingboe JW; Lombardo LJ; Alessi TR; Nguyen TT; Guzzo F; Guinosso CJ; Bullington J; Browne EN; Bagli JF; Wrenn J
    J Med Chem; 1993 Aug; 36(17):2485-93. PubMed ID: 8355249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on antidiabetic agents. Synthesis and hypoglycemic activity of 5-[4-(pyridylalkoxy)benzyl]-2,4-thiazolidinediones.
    Sohda T; Momose Y; Meguro K; Kawamatsu Y; Sugiyama Y; Ikeda H
    Arzneimittelforschung; 1990 Jan; 40(1):37-42. PubMed ID: 2339998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a novel class of orally active pyrimido[5,4-3][1,2,4]triazine-5,7-diamine-based hypoglycemic agents with protein tyrosine phosphatase inhibitory activity.
    Guertin KR; Setti L; Qi L; Dunsdon RM; Dymock BW; Jones PS; Overton H; Taylor M; Williams G; Sergi JA; Wang K; Peng Y; Renzetti M; Boyce R; Falcioni F; Garippa R; Olivier AR
    Bioorg Med Chem Lett; 2003 Sep; 13(17):2895-8. PubMed ID: 14611852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New compounds: potential antidiabetics. IV. 1-(2,4-Dinitrophenyl)-3,5-diphenyl-4-arylazopyrazoles and 1-carbamoyl-3,5-diphenyl-4-arylazopyrazoles.
    Garg HG; Singh PP
    J Pharm Sci; 1970 Jun; 59(6):876-7. PubMed ID: 5423103
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.